Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02954562 · ClinicalTrials.gov registry record
Correlates of Anxiety Associated With a Life-threatening Illness
A clinical trial, sponsored by Resilient Pharmaceuticals.
- Completed
- Registry status
- 12
- Enrollment target
NCT02954562: Completed study, sponsored by Resilient Pharmaceuticals.
NCT02954562 is a clinical trial that has completed, run by Resilient Pharmaceuticals. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02954562 has completed, sponsored by Resilient Pharmaceuticals.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The goal of this observational trial is to gather brain scan data on people undergoing MDMA-assisted therapy. The main question it aims to answer is: -How does brain activity change while completing an emotional regulation task in participants receiving MDMA-assisted therapy? Researchers will compare participants receiving MDMA-assisted therapy to participants receiving placebo plus therapy. Participants will undergo baseline brain scans with functional magnetic imaging (fMRI) while they perform an emotional regulation task and other attentional tasks. Participants will then undergo two medication sessions of MDMA or placebo-assisted therapy. Then, undergo another brain scan. Participants will then undergo a third medication session and repeat the brain scans.
Primary Outcome
Changes in brain activity during passive observation versus attempts to reduce negative response to images
Interventions
- OTHER fMRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2015-11-07 |
| Est. Completion | 2017-09-30 |
What the finished NCT02954562 record still lists
NCT02954562 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which fMRI is the first listed.
NCT02954562 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02954562 about?
NCT02954562 is a clinical study titled "Correlates of Anxiety Associated With a Life-threatening Illness". The goal of this observational trial is to gather brain scan data on people undergoing MDMA-assisted therapy. The main question it aims to answer is: -How does brain activity change while completing an emotional regulation task in participants receiving MDMA-assisted therapy? Researchers will comp...
What is the current status of trial NCT02954562?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2015-11-07. Estimated completion is 2017-09-30.
What interventions are being tested in trial NCT02954562?
The interventions under investigation include: fMRI (OTHER).
Who is sponsoring clinical trial NCT02954562?
This trial is sponsored by Resilient Pharmaceuticals, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI